Xilio Therapeutics, Inc. (XLO) quarterly income statement — complete revenue, gross profit & net income history
Xilio Therapeutics, Inc. (XLO) annual income statement — 7-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 18.69M | 12.65M | 13.69M | 19.07M | 8.08M | 2.93M | 1.72M | 2.26M | 2.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 131.22% | 331.67% | 693.85% | 742.51% | 242.98% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 344K | 0 | 0 | 15.33M | 0 | 0 | 0 | 0 | 0 | 449K | 0 | 492K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 2.72% | - | - | 189.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 18.69M | 12.3M | 13.69M | 19.07M | -7.25M | 2.93M | 1.72M | 2.26M | 2.36M | 0 | -449K | 0 | -492K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 100% | 97.28% | 100% | 100% | -89.63% | 100% | 100% | 100% | 100% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 357.96% | 319.93% | 693.85% | 742.51% | -407.42% | - | 483.96% | - | 579.07% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 22.18M | 26.42M | 25.52M | 21M | 7.12M | 16.78M | 15.35M | 17.02M | 17.06M | 17.49M | 17.68M | 17.36M | 19.62M | 23.53M | 23.17M | 20.21M | 24.55M | 21.22M | 19.56M | 15.96M |
| OpEx % of Revenue | 118.68% | 208.86% | 186.48% | 110.12% | 88.08% | 572.73% | 890.55% | 752.32% | 723.84% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 7.62M | 6.58M | 7.4M | 6.67M | 7.12M | 8.52M | 6.52M | 6.31M | 5.82M | 6.14M | 5.95M | 6.31M | 6.41M | 7.39M | 8.17M | 7.17M | 8.31M | 6.3M | 8.2M | 5.49M |
| SG&A % of Revenue | 40.79% | 52.06% | 54.07% | 35% | 88.08% | 290.61% | 378.02% | 278.7% | 246.71% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 14.56M | 19.83M | 18.12M | 14.32M | 15.33M | 8.27M | 8.84M | 10.76M | 11.22M | 10.4M | 11.74M | 11.05M | 13.22M | 16.13M | 15M | 13.04M | 16.25M | 14.92M | 11.35M | 10.47M |
| R&D % of Revenue | 77.89% | 156.8% | 132.41% | 75.11% | 189.63% | 282.12% | 512.53% | 475.43% | 475.86% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | -41K | 30K | 948K | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Operating Income | -3.49M | -14.11M | -11.84M | -1.93M | -14.37M | -13.85M | -13.63M | -14.76M | -14.7M | -17.49M | -18.13M | -17.36M | -20.12M | -23.53M | -23.17M | -20.21M | -24.55M | -21.22M | -19.56M | -15.96M |
| Operating Margin % | -18.68% | -111.58% | -86.48% | -10.12% | -177.71% | -472.73% | -790.55% | -652.32% | -623.84% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 75.7% | -1.88% | 13.16% | 86.93% | 2.3% | 20.79% | 24.83% | 14.97% | 26.9% | 25.67% | 21.74% | 14.08% | 18.07% | -10.85% | -18.46% | -26.6% | -6.72% | -28.47% | 5.04% | - |
| EBITDA | -3.16M | -13.77M | -11.51M | -1.59M | -13.98M | -13.35M | -13.25M | -14.38M | -14.26M | -17.04M | -17.68M | -16.9M | -19.62M | -23.03M | -22.68M | -19.73M | -24.11M | -20.78M | -19.16M | -15.58M |
| EBITDA Margin % | -16.91% | -108.86% | -84.12% | -8.33% | -173% | -455.77% | -768.79% | -635.48% | -604.96% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 77.4% | -3.1% | 13.14% | 88.95% | 1.92% | 21.65% | 25.04% | 14.91% | 27.34% | 25.98% | 22.03% | 14.35% | 18.6% | -10.79% | -18.35% | -26.66% | -6.51% | -28.53% | 5.39% | - |
| D&A (Non-Cash Add-back) | 331K | 344K | 323K | 340K | 381K | 497K | 375K | 381K | 445K | 443K | 449K | 460K | 492K | 499K | 489K | 473K | 445K | 440K | 394K | 382K |
| EBIT | -6.37M | -9.53M | 10.36M | -16.29M | -15.84M | -13.27M | -13.09M | -14.8M | -14.67M | -16.54M | -17.55M | -17.36M | -19.16M | -23.53M | -23.17M | -20.21M | -24.55M | -21.22M | -19.56M | -15.96M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100.4K | -200K | -199.8K | 0 | 0 | 0 | 0 | -129K | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 | 200 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 200K | 200K | 0 | 0 | 0 | 0 | 129K | 0 | 0 |
| Other Income/Expense | -2.88M | 4.58M | 22.2M | -14.36M | -1.48M | 586K | 536K | 742K | 779K | 284K | 475K | 613K | 761K | 880K | 701K | 416K | -61K | -129K | -145K | -290K |
| Pretax Income | -6.37M | -9.53M | 10.36M | -16.29M | -15.84M | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -22.65M | -22.47M | -19.79M | -24.61M | -21.35M | -19.7M | -16.25M |
| Pretax Margin % | -34.09% | -75.34% | 75.7% | -85.42% | -195.99% | -452.73% | -759.45% | -619.53% | -590.79% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.37M | -9.53M | 10.36M | -16.29M | -15.84M | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -22.65M | -22.47M | -19.79M | -24.61M | -21.35M | -19.7M | -16.25M |
| Net Margin % | -34.09% | -75.34% | 75.7% | -85.42% | -195.99% | -452.73% | -759.45% | -619.53% | -590.79% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 59.78% | 28.16% | 179.13% | -16.17% | -13.78% | 22.89% | 25.84% | 16.29% | 28.05% | 24.04% | 21.41% | 15.37% | 21.36% | -6.06% | -14.03% | -21.78% | -6.18% | -28.12% | 5.16% | - |
| Net Income (Continuing) | -6.37M | -9.53M | 10.36M | -16.29M | -15.84M | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -22.65M | -22.47M | -19.79M | -24.61M | -21.35M | -19.7M | -16.25M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.58 | 0.81 | -1.54 | -4.34 | -2.52 | -2.80 | -3.08 | -4.48 | -8.68 | -8.96 | -8.54 | -9.80 | -11.62 | -11.48 | -10.08 | -12.60 | -10.92 | -13.72 | -297.78 |
| EPS Growth % | 92.4% | 76.98% | 128.93% | 50% | 3.13% | 70.97% | 68.75% | 63.93% | 54.29% | 25.3% | 21.95% | 15.28% | 22.22% | -6.41% | 16.33% | 96.61% | 97.14% | 96.69% | 96.88% | - |
| EPS (Basic) | -0.33 | -0.58 | 0.96 | -1.54 | -4.34 | -2.52 | -2.80 | -3.08 | -4.48 | -8.68 | -8.96 | -8.54 | -9.80 | -11.62 | -11.48 | -10.08 | -12.60 | -10.92 | -13.72 | -297.78 |
| Diluted Shares Outstanding | 19.4M | 163.48M | 83.59M | 10.29M | 3.7M | 5.34M | 4.62M | 4.53M | 3.14M | 1.99M | 1.97M | 1.97M | 1.96M | 1.96M | 1.96M | 1.96M | 1.96M | 1.95M | 1.43M | 54.56K |
| Basic Shares Outstanding | 19.4M | 163.48M | 83.59M | 10.29M | 3.7M | 5.34M | 4.62M | 4.53M | 3.14M | 1.99M | 1.97M | 1.97M | 1.96M | 1.95M | 1.96M | 1.96M | 1.96M | 1.95M | 1.43M | 54.56K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |